BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2020
View Archived Issues
Transplanted iPSCs are best of both ApoE models
Read More
Keros completes dosing of planned cohorts in phase I study of KER-047
Read More
Oral RECCE-435 shows efficacy in animal model of H. pylori infection
Read More
Huya Bioscience obtains worldwide rights to SHP-2 inhibitor
Read More
IBC-Ab002 shows promising safety and efficacy in models of AD
Read More
p53 plays role of Dr. Jekyll or Mr. Hyde in gastric cancer
Read More
Betta Pharmaceuticals divulges EGFR mutant inhibitors
Read More
Merck & Co. discloses new compounds for tuberculosis
Read More
Chinese researchers present new mu-opioid receptor agonists
Read More
New HER2 inhibitors presented by Taiho Pharmaceutical
Read More
Voronoi patent details RIP-1 inhibitors
Read More
IMV receives funding for phase I study of DPX-COVID-19 vaccine
Read More
MODAG completes first phase I study of Anle-138b
Read More
Revive finalizing details for phase III study of bucillamine in COVID-19
Read More
HTA presents new prostate cancer diagnosis probe [68Ga]DOTA-ANCP-PSMA
Read More
Positive preliminary data presented from diverticulosis pilot trial of PGLG
Read More
Personalized TLPLDC vaccine demonstrates long-term survival benefit in high-risk melanoma
Read More
Phase III study of CS-1001 as first-line treatment of NSCLC meets primary endpoint
Read More
Genetic variant in IFITM3 gene tied to disease severity in COVID-19 disease
Read More
FDA approves Blenrep for relapsed or refractory multiple myeloma
Read More
Lundbeck discontinues phase II study of Lu-AF-11167
Read More
Phase II study of BioAegis' gelsolin for COVID-19 begins in Spain
Read More
